NRIX — NURIX THERAPEUTICS INC

Ownership history in BBR PARTNERS, LLC  ·  10 quarters on record

This page tracks every 13F SEC filing in which BBR PARTNERS, LLC reported a position in NURIX THERAPEUTICS INC (NRIX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.04% (2024 Q3)
Avg. % of fund
0.02%
First filed
2023 Q1
Last filed
2025 Q3
Quarters held
10
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 20,988 — 0% 0.01% $194K $9.24
2025 Q2 UNCHANGED 20,988 — 0% 0.01% $239K $11.39
2025 Q1 UNCHANGED 20,988 — 0% 0.02% $249K $11.88
2024 Q4 UNCHANGED 20,988 — 0% 0.03% $395K $18.84
2024 Q3 UNCHANGED 20,988 — 0% 0.04% $472K $22.47
2024 Q2 UNCHANGED 20,988 — 0% 0.04% $438K $20.87
2024 Q1 UNCHANGED 20,988 — 0% 0.02% $309K $14.70
2023 Q4 UNCHANGED 20,988 — 0% 0.02% $217K $10.32
2023 Q3 UNCHANGED 20,988 — 0% 0.02% $165K $7.86
2023 Q1 INITIATED 20,988 — — 0.02% $186K $8.88
% of Fund (quarterly)    NRIX price (monthly, adj. close)

Other funds also holding NRIX

As of 2025 Q4 — sorted by position size

Redmile Group, LLC 3Y 7Y 11.31% GENERAL ATLANTIC, L.P. 3Y 7Y 3.23% Vestal Point Capital, LP 3.02% Commodore Capital LP 3Y 2.87% Elmind Capital, LP 2.58% Kynam Capital Management, LP 3Y 2.39% Deep Track Capital, LP 3Y 2.38% Longaeva Partners L.P. 1.48% BRAIDWELL LP 3Y 1.32% PERCEPTIVE ADVISORS LLC 3Y 7Y 1.2%
← Back to BBR PARTNERS, LLC Holdings